The successful treatment of molluscum contagiosum with podophyllotoxin (0.5%) self-application [2]

International Journal of STD and AIDS

Volumn 12, Issue 12, 2001, Pages 833-

  Markos, A R ^a  

^a STAFFORDSHIRE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PODOPHYLLOTOXIN;

CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; LETTER; MOLLUSCUM CONTAGIOSUM; PAIN; PRIORITY JOURNAL; SCAR FORMATION; SELF MEDICATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; HUMANS; MOLLUSCUM CONTAGIOSUM; MOLLUSCUM CONTAGIOSUM VIRUS; PODOPHYLLOTOXIN;

EID: 0035204088     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient
2. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study